AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Amgen
Related studies linked through entity extraction aliases.
Real World Study to Describe the Effectiveness and Safety of Teprotumumab Among Thyroid Eye Disease Patients
- Status
- COMPLETED
- Phase
- N/A
Olpasiran Expanded Access Program
- Status
- AVAILABLE
- Phase
- N/A
Refractory Advanced diGestive Neuroendocrine Carcinomas Treated With tARlatamab
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
- Status
- RECRUITING
- Phase
- PHASE1
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Status
- RECRUITING
- Phase
- PHASE3
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Status
- RECRUITING
- Phase
- PHASE3
Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocrine Carcinomas (NECs), With Biomarker Analysis to Characterize Response/Resistance (UNLOCK TARLATAMAB)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
TIDHI Mental Health in IBD Patients Study
- Status
- RECRUITING
- Phase
- NA
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
- Status
- RECRUITING
- Phase
- PHASE3
Efficacy and Safety of Maridebart Cafraglutide in Adult Participants in Japan Who Have Obesity Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate AMG 133 Administered Subcutaneously in Participants With Overweight or Obesity
- Status
- COMPLETED
- Phase
- PHASE1
Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes
- Status
- WITHDRAWN
- Phase
- PHASE2
Single and Multiple Ascending Dose Study of AMG 378 in Healthy Participants
- Status
- TERMINATED
- Phase
- PHASE1
Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Status
- RECRUITING
- Phase
- PHASE3
Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3